Parsec Financial Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-710
| Closed | -$235K | – | 308 |
|
|
2022
Q1 | $235K | Hold |
710
| – | – | 0.01% | 277 |
|
|
2021
Q4 | $255K | Hold |
710
| – | – | 0.01% | 264 |
|
|
2021
Q3 | $264K | Hold |
710
| – | – | 0.01% | 253 |
|
|
2021
Q2 | $222K | Hold |
710
| – | – | 0.01% | 254 |
|
|
2021
Q1 | $226K | Hold |
710
| – | – | 0.01% | 244 |
|
|
2020
Q4 | $230K | Buy |
+710
| New | +$230K | 0.01% | 236 |
|
|
2019
Q3 | – | Sell |
-788
| Closed | -$205K | – | 253 |
|
|
2019
Q2 | $205K | Hold |
788
| – | – | 0.01% | 226 |
|
|
2019
Q1 | $225K | Hold |
788
| – | – | 0.01% | 218 |
|
|
2018
Q4 | $256K | Hold |
788
| – | – | 0.02% | 207 |
|
|
2018
Q3 | $354K | Buy |
788
+78
| +11% | +$35K | 0.02% | 196 |
|
|
2018
Q2 | $290K | Hold |
710
| – | – | 0.02% | 202 |
|
|
2018
Q1 | $207K | Buy |
+710
| New | +$207K | 0.01% | 217 |
|